Bioceramics market was valued at $8.2 billion in 2024 and is projected to reach $15.8 billion by 2035, growing at a CAGR of 7.3% during the forecast period (2025–2035). Bioceramic implants made by additive manufacturing (AM), commonly known as 3D printing, are emerging as attractive therapy options for bone repair engineering. On the one hand, additively created bioceramic implants have superior mechanical qualities and biocompatibility, making them ideal for bone regeneration. In contrast, the designable structure and customizable porosity of additively created bioceramic implants enable them to stimulate appropriate cell development and tissue ingrowth.
Browse the full report description of “Bioceramics Market Size, Share & Trends Analysis Report by Source (Microbial, Mammalian, and Others) by Product Type (Monoclonal Antibodies (mAbs), Vaccines, Recombinant Proteins, Gene Therapy, Cell Therapy and Others) by Application (Therapeutics, Diagnostics, Research Applications and Preventive), By Manufacturing Type (In-house Manufacturing, Contract Manufacturing) Forecast Period (2025-2035)” at https://www.omrglobal.com/industry-reports/bioceramics-market
As demand continues to rise for advanced materials in the medical and dental industries, major players in the global bioceramic market are making strategic investments to expand research, innovation, and production capabilities. In May 2024, Lithoz and bioceramic materials manufacturer Himed opened a new Bioceramics Center of Excellence (BCoE) at Himed’s New York headquarters. The two businesses have been collaborating since 2023 and established the BCoE to give medical device manufacturers access to a comprehensive approach to bioceramics research and development. With Lithoz's Lithography-based Ceramic Manufacturing (LCM) 3D printing technology being used on-site, the BCoE will facilitate the fast prototype process by integrating a number of analytical services. The Lithoz LCM 3D printing technology will be essential to Himed's rapid prototyping capabilities, since it will enable the company to sell 3D-printed implants to medical device manufacturers. SEM imaging, material analysis and characterization, biomaterial customization, and bioceramic 3D printing using the Lithoz CeraFab S65 Medical printer will all be offered by the facility, along with design support and optimization services.
Over the past ten years, 3D-printing joint implant technology has gained popularity in Europe. Expanded access for compassionate use in the United States is now granted by the FDA. Currently, the procedure takes roughly three months from diagnosis to FDA approval, Institutional Review Board approval, design, manufacture, and surgery. Cleveland Clinic has one of the largest patient numbers and is one of the few facilities in the US to provide this innovative service.
Market Coverage
Key questions addressed by the report.
Global Bioceramic Market Report Segment
By Product Type
By Application
Global Bioceramic Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/bioceramics-market